Position in NVS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$6,882,358
-$588,033 QoQ
Shares Held
43,915
-10.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#220
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PARK AVENUE SECURITIES LLC holds $165,157,657 across 14 Drug Manufacturers - General names. NVS ranks #8 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,602 | $42,702,110 | |
| 2 | JNJ |
Johnson & Johnson
|
119,431 | $30,331,891 | |
| 3 | ABBV |
AbbVie Inc.
|
98,903 | $24,887,950 | |
| 4 | MRK |
Merck & Co., Inc.
|
106,866 | $13,732,281 | |
| 5 | AZN |
Astrazeneca PLC
|
53,856 | $10,212,174 | |
| 6 | AMGN |
Amgen Inc
|
27,835 | $10,079,610 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
71,241 | $9,000,587 | |
| 8 | NVS |
Novartis AG
This page
|
43,915 | $6,882,358 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,882,358 | 43,915 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $7,470,391 | 48,906 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $6,697,586 | 48,579 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $6,782,870 | 52,892 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $6,694,152 | 55,319 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $5,184,711 | 46,508 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $4,196,688 | 43,127 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $3,778,522 | 32,851 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $3,670,953 | 34,482 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $2,671,682 | 27,620 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $3,243,358 | 32,122 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $3,064,254 | 30,083 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,890,163 | 28,641 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,173,500 | 23,625 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,163,127 | 23,844 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,577,435 | 20,753 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,635,148 | 19,344 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,451,560 | 16,542 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,238,050 | 14,154 | Shares | Sole | 2022-04-08 | |
| 2021-09-30 | $1,283,782 | 15,698 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $1,358,016 | 14,884 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,238,263 | 14,486 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,354,031 | 14,339 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $1,202,048 | 13,823 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,147,560 | 13,139 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $792,344 | 9,610 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||